Skip to content
NewCybercrime Report 2026 · Eight Chapters · A Post Is Not An Incident → Explore The ChaptersCybercrime Report 2026 → Explore

OpenEMR Fee Sheet SQL Injection (CVE-2026-124469)

CVE-2026-124469 is a critical SQL injection vulnerability in the OpenEMR Fee Sheet drug-inventory lookup.

Reviewed by
Brandefense Analyst Team
Published
Reading Time
2 min read
CVE ID
CVE-2026-124469
Vendor
OpenEMR
Affected Product
OpenEMR
Published
2026-11-08

The flaw affects OpenEMR versions before 8.3.0.The vendor advisory says an untrusted warehouse value reaches a dynamically built database sort clause without adequate validation. An authenticated user with Fee Sheet access can abuse the flaw to read data through a blind timing channel.

What it allows

How Does CVE-2026-124469 Affect OpenEMR?

An attacker needs an authenticated account whose role can use the Fee Sheet form. The vendor says a default installation can grant this access to low-privileged clinical staff.

Successful exploitation can expose data across the OpenEMR database. The advisory specifically identifies patient records and password hashes as accessible information, creating further account-takeover risk.

The vendor describes the direct database primitive as read-only under default grants. It also states that the default configuration does not provide a path to remote code execution.

Who is affected

OpenEMR versions earlier than 8.3.0 are affected. The GitHub security advisory identifies OpenEMR 8.3.0 as the patched version.

Exposure depends on whether an authenticated role can access the Fee Sheet workflow. Internet-facing login access increases the opportunity for a compromised low-privileged account to reach the vulnerable function.

What to do

  1. Upgrade OpenEMR to version 8.3.0 or later

    Prioritize systems where clinical staff or other low-privileged roles can use Fee Sheets. Confirm the running application version after deployment.

  2. Review Fee Sheet permissions

    Brandefense recommends limiting Fee Sheet access to staff who need it. Remove unnecessary access while the upgrade is being completed.

  3. Investigate unusual Fee Sheet activity

    Brandefense recommends reviewing application and database logs for repeated or unusual Fee Sheet submissions. Preserve relevant logs and investigate activity tied to unexpected accounts.

  4. Assess exposed credentials after suspected abuse

    The advisory says the flaw can expose password hashes. If investigation indicates abuse, follow the organization's credential reset and incident response procedures.

What Brandefense can do

Frequently Asked Questions

What is CVE-2026-124469?

It is an SQL injection vulnerability in the OpenEMR Fee Sheet drug-inventory lookup. The flaw can let an authenticated user with Fee Sheet access read sensitive database information.

Which OpenEMR versions are affected by CVE-2026-124469?

The GitHub security advisory lists OpenEMR versions before 8.3.0 as affected. It identifies version 8.3.0 as patched.

Does CVE-2026-124469 require authentication?

Yes. The advisory says exploitation requires an authenticated role that can access the Fee Sheet form, including certain low-privileged clinical roles in a default installation.

What should OpenEMR administrators do first?

Upgrade to OpenEMR 8.3.0 or later. Administrators should also review Fee Sheet permissions and investigate unusual submissions while completing the upgrade.

Sources

  1. OpenEMR GitHub Security Advisory: GHSA-cg8c-2v5q-29g7GitHub
  2. NVD: CVE-2026-124469NIST NVD
ShareLinkedInX
Brandefense logo

Stay Ahead of Digital Threats.

Take control of your digital security with an exclusive demo of our AI-driven threat intelligence platform.

Open The Full Demo Form →